Since the progression of ALK-positive ALCL is influenced by therapy-independent and therapy-induced anti-tumor immune response, we investigated whether the genotype of 14 cancer-immunity relevant SNPs might correlate with lymphoma presentation and recurrence, as well as with histological features of ALK-positive ALCL. The gene discussed is ALK; the disease is lymphoma.